Concepedia

Publication | Open Access

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

DOIFull Paper Access

465

Citations

25

References

2016

Year

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George, Cem Akin, Karl Sotlar, Olivier Hermine, Farrukh T. Awan, Elizabeth O. Hexner, Michael J. Mauro, David Sternberg,
New England Journal of Medicine

Abstract

In this open-label study, midostaurin showed efficacy in patients with advanced systemic mastocytosis, including the highly fatal variant mast-cell leukemia. (Funded by Novartis Pharmaceuticals and others; ClinicalTrials.gov number, NCT00782067.).

References

YearCitations

Page 1